Intel, Dynavax, and Snowflake: Stock Movers on Wall Street

Intel's Chip Production Challenges

• 📉 Intel (INTC) shares declined following a Reuters report that Nvidia halted testing of Intel's 18A production process for advanced chips.
• 💡 This halt is critical for Intel's turnaround strategy, especially after Nvidia's September agreement to invest $5 billion in Intel for co-developing PC and data center chips.

Dynavax Acquisition by Sanofi

• 🚀 Dynavax (DVAX) shares surged by 38% after French pharmaceutical company Sanofi announced a cash tender offer to acquire the vaccine maker for $15.50 per share, totaling approximately $2.2 billion.
• 💉 This acquisition grants Sanofi access to vaccines, including hepatitis B vaccines, and aims to boost Sanofi's revenue amidst challenges in the global vaccine market.

Snowflake's Potential Acquisition

• 📊 Snowflake (SNOW) experienced a dip in shares after The Information reported the software company is in talks to acquire the startup Observe Inc. for around $1 billion.
• 🛠️ Observe Inc. develops tools that help developers track app performance, and analysts believe this potential deal could enhance Snowflake's ability to compete with companies like Databricks.